BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

被引：0
作者：
A. S. Hamy
I. Bieche
J. Lehmann-Che
V. Scott
Ph. Bertheau
J. M. Guinebretière
M. C. Matthieu
B. Sigal-Zafrani
O. Tembo
M. Marty
B. Asselain
F. Spyratos
P. de Cremoux
机构：
[1] Institut Curie,Department of Biostatistics
[2] Institut Curie,Pharmacogenomics Unit, Department of Genetics
[3] Paris Diderot University,APHP Molecular Oncology Unit, Hôpital Saint Louis
[4] Institut Gustave Roussy,Biology Department
[5] Paris Diderot University,APHP Pathology Department, Hôpital Saint Louis
[6] Institut Curie,Pathology Department, Hôpital René
[7] Institut Gustave Roussy,Huguenin
[8] Institut Curie,Pathology Department
[9] Saint-Louis Hospital,Pathology Department
来源：
Breast Cancer Research and Treatment | 2016年 / 159卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; Predictive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 511
页数：12
相关论文
共 50 条
[21]   Results response of neoadjuvant chemotherapy for stage III breast carcinoma at Viet Nam National Cancer Hospital [J].
Thien, Nguyen Truong ;
Quang, Le Hong ;
Trung, Nguyen Ngoc .
BIOMEDICAL RESEARCH AND THERAPY, 2024, 11 (11) :6923-6931
[22]   99mTc-3PRGD2 SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer [J].
Bin Ji ;
Bin Chen ;
Ting Wang ;
Yan Song ;
Minglong Chen ;
Tiefeng Ji ;
Xueju Wang ;
Shi Gao ;
Qingjie Ma .
European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 :1362-1370
[23]   99mTc-3PRGD2 SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer [J].
Ji, Bin ;
Chen, Bin ;
Wang, Ting ;
Song, Yan ;
Chen, Minglong ;
Ji, Tiefeng ;
Wang, Xueju ;
Gao, Shi ;
Ma, Qingjie .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (09) :1362-1370
[24]   Haematological toxicity: A marker of adjuvant chemotherapy efficacy in stage II and III breast cancer [J].
Saarto, T ;
Blomqvist, C ;
Rissanen, P ;
Auvinen, A ;
Elomaa, I .
BRITISH JOURNAL OF CANCER, 1997, 75 (02) :301-305
[25]   Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease [J].
Falo, Catalina ;
Azcarate, Juan ;
Fernandez-Gonzalez, Sergi ;
Perez, Xavier ;
Petit, Ana ;
Perez, Hector ;
Vethencourt, Andrea ;
Vazquez, Silvia ;
Laplana, Maria ;
Ales, Miriam ;
Stradella, Agostina ;
Fullana, Bartomeu ;
Pla, Maria J. ;
Guma, Anna ;
Ortega, Raul ;
Varela, Mar ;
Perez, Diana ;
Ponton, Jose Luis ;
Cobo, Sara ;
Benitez, Ana ;
Campos, Miriam ;
Fernandez, Adela ;
Villanueva, Rafael ;
Obadia, Veronica ;
Recalde, Sabela ;
Soler-Monso, Teresa ;
Lopez-Ojeda, Ana ;
Martinez, Evelyn ;
Ponce, Jordi ;
Pernas, Sonia ;
Gil-Gil, Miguel ;
Garcia-Tejedor, Amparo .
CANCERS, 2024, 16 (13)
[26]   Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer [J].
Bhuvaneswari Ramaswamy ;
Steven P Povoski ;
Chris Rhoades ;
Joan Allen ;
Marsha Hauger ;
Donn Young ;
William Burak ;
William Farrar ;
Lisa Yee ;
Kari Kendra ;
Sivagurunathan Somasundaram ;
Robert Z Orlowski ;
Charles L. Shapiro .
Breast Cancer Research and Treatment, 2005, 93 :67-74
[27]   Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy [J].
Kim, Hyori ;
Youk, Jeonghwan ;
Yang, Yaewon ;
Kim, Tae-Yong ;
Min, Ahrum ;
Ham, Hye-Seon ;
Cho, Seongcheol ;
Lee, Kyung-Hun ;
Keam, Bhumsuk ;
Han, Sae-Won ;
Oh, Do-Youn ;
Ryu, Han Suk ;
Han, Wonshik ;
Park, In Ae ;
Kim, Tae-You ;
Noh, Dong-Young ;
Im, Seock-Ah .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (03) :707-714
[28]   Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy [J].
Hyori Kim ;
Jeonghwan Youk ;
Yaewon Yang ;
Tae-Yong Kim ;
Ahrum Min ;
Hye-Seon Ham ;
Seongcheol Cho ;
Kyung-Hun Lee ;
Bhumsuk Keam ;
Sae-Won Han ;
Do-Youn Oh ;
Han Suk Ryu ;
Wonshik Han ;
In Ae Park ;
Tae-You Kim ;
Dong-Young Noh ;
Seock-Ah Im .
Journal of Cancer Research and Clinical Oncology, 2016, 142 :707-714
[29]   Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer [J].
White, Rohen ;
Dinneen, Tamara ;
Makris, Andreas .
RADIATION ONCOLOGY, 2016, 11
[30]   Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer [J].
Rohen White ;
Tamara Dinneen ;
Andreas Makris .
Radiation Oncology, 11
12345